👉 Most biotech teams do not struggle because they lack ideas, data, or scientific depth. They struggle because every decision feels heavy , and focus starts to feel like a loss rather than a gain. 👉 In early-stage biotech, this tension shows up quietly. Founders hesitate to narrow their scope , not because they are unfocused, but because they are afraid of closing doors too early. Every program feels promising. Every dataset suggests another possible direction. And without